NCT05334758 Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test Status COMPLETED Phase NA
NCT05334680 International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms Status UNKNOWN Phase N/A
NCT05334134 COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children Status UNKNOWN Phase N/A
NCT05331976 A Clinical Evaluation of Proof Diagnostics Test System Including the Proof Diagnostics Reader and COVID-19 Test Status COMPLETED Phase N/A
NCT05330871 Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years. Status UNKNOWN Phase PHASE2
NCT05329064 Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children Status UNKNOWN Phase PHASE4
NCT05329051 A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years Status UNKNOWN Phase PHASE2
NCT05329038 Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05328479 Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand Status COMPLETED Phase N/A
NCT05324319 Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients Status UNKNOWN Phase PHASE2
NCT05323994 Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR) Status COMPLETED Phase N/A
NCT05323851 How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC) Status COMPLETED Phase N/A
NCT05323799 The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05323461 A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines Status UNKNOWN Phase PHASE3
NCT05323435 Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV) Status COMPLETED Phase PHASE2